GDF15 mediates the effects of metformin on body weight and energy balance
Metformin, the world’s most prescribed anti-diabetic drug, is also effective in preventing type 2 diabetes in people at high risk1,2. More than 60% of this effect is attributable to the ability of metformin to lower body weight in a sustained manner3. The molecular mechanisms by which metformin lowe...
Κύριοι συγγραφείς: | Coll, A, Chen, M, Taskar, P, Preiss, D, et al. |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Nature Research
2019
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin
ανά: Jing Ouyang, κ.ά.
Έκδοση: (2020-11-01) -
The gastrointestinal tract is a major source of the acute metformin-stimulated rise in GDF15
ανά: John W. R. Kincaid, κ.ά.
Έκδοση: (2024-01-01) -
Research progress on the role and mechanism of GDF15 in body weight regulation
ανά: Xiao-Chen Dong, κ.ά.
Έκδοση: (2023-11-01) -
Fc-GDF15 glyco-engineering and receptor binding affinity optimization for body weight regulation
ανά: Ella Fung, κ.ά.
Έκδοση: (2021-04-01) -
SCAP Mediated GDF15-Induced Invasion and EMT of Esophageal Cancer
ανά: Gang Dong, κ.ά.
Έκδοση: (2020-10-01)